Improving Outcomes for Child and Youth Victims of Human Trafficking

OVC FY 2026 Services for Victims of Human Trafficking is sponsored by Office for Victims of Crime (OVC), U.S. Department of Justice (DOJ). This program aims to develop, expand, and strengthen victim service programs for victims of all forms of human trafficking throughout the United States and its territories. It provides funding for comprehensive and specialized services for victims of human trafficking and is intended for victim services programs serving adults or a combination of adults and minors/youth.

OVC FY 2026 Integrated Services for Minor Victims of Human Trafficking is sponsored by Office for Victims of Crime (OVC), U.S. Department of Justice (DOJ). This program focuses on providing integrated services for minor victims of human trafficking. Similar to the Housing Assistance program, this may be relevant to organizations serving sexual assault victims who are minors and have experienced trafficking.

OVC FY 2026 Housing Assistance for Victims of Human Trafficking is sponsored by Office for Victims of Crime (OVC), U.S. Department of Justice (DOJ). This funding opportunity provides support for housing assistance to victims of human trafficking. While not exclusively focused on sexual assault, human trafficking often involves sexual exploitation, making it potentially relevant for organizations serving sexual assault victims who have also experienced trafficking.

Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Idea Development Award (IDA) promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports impactful, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with Duchenne muscular dystrophy (DMD) in the near term. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale. The DMDRP strongly encourages research projects investigating therapies designed to demonstrate efficacy cross the life span, including infants, toddlers and nonambulatory individuals.Distinctive Features: The FY26 DMDRP IDA mechanism offers three eligibility career categories:• The Established Investigator category is for independent investigators at all academic levels, or equivalent• The New Investigator – Early-Stage category is for independent investigators early in their careers (i.e., within 10 years of their first faculty appointment or equivalent). Applicants in this category will be reviewed separately from Established Investigators.• The New Investigator – Transitioning category is for independent investigators at all academic levels, or equivalent, in an area other than muscular dystrophy who are seeking to transition to a career in DMD, thereby bringing their expertise to the field. Applicants in this category will be reviewed separately from Established Investigators.Preliminary data relevant to DMD that supports the feasibility of the research hypotheses and research approaches are required for all applications. Clinical trials or clinical trial aims are not allowed. Funding Opportunity Number: HT942526DMDRPIDA. Assistance Listing: 12.420. Funding Instrument: G. Category: ST. Award Amount: $2.5M total program funding.